Clinical and functional significance of circular RNAs in cytogenetically normal AML.
      QxMD      Google Scholar   
Citation:
Blood Adv vol 4 (2) 239-251
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Received
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
9
Parents:
2924  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
Novartis (10603), BMS (10503)  
Grants:
U10CA180821, U10CA180882, U10CA180833, U10CA180850, U10CA180866, U10CA180867  
Corr. Author:
 
Authors:
                                               
Networks:
CT063, LAPS-AL002, LAPS-MA036, LAPS-MO011, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL, OH070   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8721, CALGB-8821, CALGB-10503, CALGB-10603, CALGB-19808, CALGB-8525, CALGB-9022, CALGB-9120, CALGB-9222
Phases:
2, 3
Keywords:
Adolescent, Adult, Cytogenetics, Female, Humans, Leukemia, Myeloid, Acute, Male, Middle Aged, Prognosis, RNA, Circular, Young Adult